We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Medpace
MEDP
$16.1B
| $313K | ﹤0.01% |
8,626
-1,312
| -13% | -$46K |
|
|
EGIO
2452
DELISTED
Edgio, Inc. Common Stock
EGIO
| $313K | ﹤0.01% |
1,772
-320
| -15% | -$63.2K |
|
2453
PC Connection
CNXN
$2.08B
| $312K | ﹤0.01% |
11,914
-1,910
| -14% | -$51.7K |
|
2454
Johnson Outdoors
JOUT
$493M
| $311K | ﹤0.01% |
5,014
-1,183
| -19% | -$82.8K |
|
2455
Alpha and Omega Semiconductor
AOSL
$931M
| $310K | ﹤0.01% |
18,919
-3,247
| -15% | -$56.8K |
|
|
GNRT
2456
DELISTED
Gener8 Maritime, Inc.
GNRT
| $310K | ﹤0.01% |
46,858
-7,562
| -14% | -$36.2K |
|
2457
1-800-Flowers.com
FLWS
$246M
| $309K | ﹤0.01% |
28,891
-4,480
| -13% | -$44.7K |
|
2458
Anterix
ATEX
$1.82B
| $308K | ﹤0.01% |
9,607
-1,671
| -15% | -$53.8K |
|
2459
FRP Holdings
FRPH
$433M
| $308K | ﹤0.01% |
13,908
-2,480
| -15% | -$55.4K |
|
2460
Lands' End
LE
$369M
| $307K | ﹤0.01% |
15,697
-1,740
| -10% | -$24K |
|
2461
Madrigal Pharmaceuticals
MDGL
$11.4B
| $307K | ﹤0.01% |
+3,342
| New | +$191K |
|
|
DS
2462
DELISTED
Drive Shack Inc.
DS
| $307K | ﹤0.01% |
55,489
-20,517
| -27% | -$97.4K |
|
|
EEX
2463
DELISTED
Emerald Holding
EEX
| $304K | ﹤0.01% |
14,930
-2,698
| -15% | -$59.7K |
|
2464
Intellia Therapeutics
NTLA
$1.55B
| $303K | ﹤0.01% |
15,750
-1,706
| -10% | -$39.4K |
|
2465
DHT Holdings
DHT
$2.99B
| $302K | ﹤0.01% |
84,245
-10,966
| -12% | -$42.5K |
|
2466
Energy Recovery
ERII
$435M
| $302K | ﹤0.01% |
34,542
-6,205
| -15% | -$56.6K |
|
|
WFBI
2467
DELISTED
WashingtonFirst Bankshares Inc
WFBI
| $302K | ﹤0.01% |
8,809
-1,585
| -15% | -$55.1K |
|
2468
Winmark
WINA
$1.19B
| $301K | ﹤0.01% |
2,327
-428
| -16% | -$56.6K |
|
|
VWTR
2469
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $301K | ﹤0.01% |
23,487
-5,206
| -18% | -$83.2K |
|
2470
Codexis
CDXS
$159M
| $300K | ﹤0.01% |
35,893
-7,529
| -17% | -$52.1K |
|
2471
Preformed Line Products
PLPC
$1.8B
| $300K | ﹤0.01% |
4,228
-530
| -11% | -$39.3K |
|
2472
W&T Offshore
WTI
$515M
| $300K | ﹤0.01% |
90,685
-16,857
| -16% | -$52.3K |
|
|
RSO
2473
DELISTED
Resource Capital Corp.
RSO
| $300K | ﹤0.01% |
32,037
-5,336
| -14% | -$53.4K |
|
|
GPX
2474
DELISTED
GP Strategies Corp.
GPX
| $298K | ﹤0.01% |
12,847
-1,919
| -13% | -$50.1K |
|
2475
Primis Financial Corp
FRST
$396M
| $297K | ﹤0.01% |
18,510
-184
| -1% | -$3.05K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.